Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,265
archived clinical trials in
Rheumatoid Arthritis

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Denver Hip and Knee, Inc.
1755
mi
from 02139
Parker, CO
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Denver Hip and Knee, Inc.
1755
mi
from 02139
Parker, CO
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Connecticut Joint Replacement Institute (CJRI)
91
mi
from 02139
Hartford, CT
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Connecticut Joint Replacement Institute (CJRI)
91
mi
from 02139
Hartford, CT
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Florida Orthopaedic Institute
1172
mi
from 02139
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Florida Orthopaedic Institute
1172
mi
from 02139
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
FMC Orthopedic Division
1182
mi
from 02139
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
FMC Orthopedic Division
1182
mi
from 02139
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Resurgens Orthopaedics
941
mi
from 02139
Austell, GA
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Resurgens Orthopaedics
941
mi
from 02139
Austell, GA
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
OrthoCarolina Hip & Knee Center
719
mi
from 02139
Charlotte, NC
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
OrthoCarolina Hip & Knee Center
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Memorial Bone & Joint
1608
mi
from 02139
Houston, TX
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Memorial Bone & Joint
1608
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Elective Orthopaedic Centre
mi
from 02139
Epsom,
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Elective Orthopaedic Centre
mi
from 02139
Epsom,
Click here to add this to my saved trials
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated:  12/31/1969
AARDS Research, Inc
1243
mi
from 02139
Aventura, FL
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated: 12/31/1969
AARDS Research, Inc
1243
mi
from 02139
Aventura, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Rheum Assoc of North Alabama /ID# 135926
mi
from 02139
Huntsville, AL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Rheum Assoc of North Alabama /ID# 135926
mi
from 02139
Huntsville, AL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AZ Arthritis and Rheum Researc /ID# 135902
mi
from 02139
Phoenix, AZ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis and Rheum Researc /ID# 135902
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AZ Arthritis & Rheuma Research /ID# 135931
mi
from 02139
Phoenix, AZ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis & Rheuma Research /ID# 135931
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 124092
2535
mi
from 02139
Hemet, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 124092
2535
mi
from 02139
Hemet, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Ucsd /Id# 128747
2574
mi
from 02139
La Jolla, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Ucsd /Id# 128747
2574
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances /ID# 135911
2504
mi
from 02139
Palm Desert, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances /ID# 135911
2504
mi
from 02139
Palm Desert, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Orrin Troum, M.D. and Medical /ID# 135933
mi
from 02139
Santa Monica, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Orrin Troum, M.D. and Medical /ID# 135933
mi
from 02139
Santa Monica, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Robin K. Dore MD, Inc /ID# 135906
2575
mi
from 02139
Tustin, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Robin K. Dore MD, Inc /ID# 135906
2575
mi
from 02139
Tustin, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Inland Rheum Clin Trials Inc. /ID# 136716
mi
from 02139
Upland, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Inland Rheum Clin Trials Inc. /ID# 136716
mi
from 02139
Upland, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Desert Valley Medical Group /ID# 135932
mi
from 02139
Victorville, CA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Desert Valley Medical Group /ID# 135932
mi
from 02139
Victorville, CA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Denver Arthritis Clinic, PC /ID# 135901
1758
mi
from 02139
Denver, CO
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Denver Arthritis Clinic, PC /ID# 135901
1758
mi
from 02139
Denver, CO
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
AARDS Research, Inc. /ID# 135910
1243
mi
from 02139
Aventura, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
AARDS Research, Inc. /ID# 135910
1243
mi
from 02139
Aventura, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
RASF - Clinical Research /ID# 124082
1216
mi
from 02139
Boca Raton, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
RASF - Clinical Research /ID# 124082
1216
mi
from 02139
Boca Raton, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants, LLC /ID# 124094
mi
from 02139
DeBary, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants, LLC /ID# 124094
mi
from 02139
DeBary, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
University of Florida /ID# 124087
1015
mi
from 02139
Jacksonville, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
University of Florida /ID# 124087
1015
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Suncoast Research Group, LLC /ID# 137774
1257
mi
from 02139
Miami, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Suncoast Research Group, LLC /ID# 137774
1257
mi
from 02139
Miami, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Omega Research Consultants /ID# 137398
mi
from 02139
Orlando, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Omega Research Consultants /ID# 137398
mi
from 02139
Orlando, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Millennium Research /ID# 135917
1060
mi
from 02139
Ormond Beach, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Millennium Research /ID# 135917
1060
mi
from 02139
Ormond Beach, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis Center, Inc. /ID# 124090
1183
mi
from 02139
Palm Harbor, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis Center, Inc. /ID# 124090
1183
mi
from 02139
Palm Harbor, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources, Inc. /ID# 128745
1230
mi
from 02139
Venice, FL
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources, Inc. /ID# 128745
1230
mi
from 02139
Venice, FL
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
North Georgia Rheumatology Grp /ID# 128746
mi
from 02139
Lawrenceville, GA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
North Georgia Rheumatology Grp /ID# 128746
mi
from 02139
Lawrenceville, GA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Kansas City Internal Medicine /ID# 135916
1253
mi
from 02139
Overland Park, KA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Kansas City Internal Medicine /ID# 135916
1253
mi
from 02139
Overland Park, KA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
PRN Professional Research Network of Kansas, LLC /ID# 124091
mi
from 02139
Wichita, KA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
PRN Professional Research Network of Kansas, LLC /ID# 124091
mi
from 02139
Wichita, KA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Klein and Associates, MD., PA /ID# 124086
393
mi
from 02139
Hagerstown, MD
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Klein and Associates, MD., PA /ID# 124086
393
mi
from 02139
Hagerstown, MD
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
The Center for Rheumatology & /ID# 124077
mi
from 02139
Wheaton, MD
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology & /ID# 124077
mi
from 02139
Wheaton, MD
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Study Gr /ID# 124079
mi
from 02139
Worcester, MA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Gr /ID# 124079
mi
from 02139
Worcester, MA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Justus J. Fiechtner, MD, PC /ID# 124081
mi
from 02139
Lansing, MI
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Justus J. Fiechtner, MD, PC /ID# 124081
mi
from 02139
Lansing, MI
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Summit Medical Group /ID# 124076
mi
from 02139
Clifton, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Summit Medical Group /ID# 124076
mi
from 02139
Clifton, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis and Osteoporosis /ID# 135907
mi
from 02139
Freehold, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis and Osteoporosis /ID# 135907
mi
from 02139
Freehold, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis Rheumatic Back Disorder /ID# 135913
mi
from 02139
Voorhees, NJ
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis Rheumatic Back Disorder /ID# 135913
mi
from 02139
Voorhees, NJ
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Arthritis and Osteo Assoc /ID# 132280
mi
from 02139
Las Cruces, NM
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Arthritis and Osteo Assoc /ID# 132280
mi
from 02139
Las Cruces, NM
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
DJL Clinical Research, PLLC /ID# 131936
726
mi
from 02139
Charlotte, NC
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
DJL Clinical Research, PLLC /ID# 131936
726
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Rheumatic Disease /ID# 135921
mi
from 02139
Cincinnati, OH
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Rheumatic Disease /ID# 135921
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
STAT Research, Inc. /ID# 134906
705
mi
from 02139
Dayton, OH
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
STAT Research, Inc. /ID# 134906
705
mi
from 02139
Dayton, OH
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Health Research of Oklahoma /ID# 135904
1490
mi
from 02139
Oklahoma City, OK
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Health Research of Oklahoma /ID# 135904
1490
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
East Penn Rheumatology Assoc /ID# 135920
mi
from 02139
Bethlehem, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
East Penn Rheumatology Assoc /ID# 135920
mi
from 02139
Bethlehem, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Altoona Ctr Clinical Res /ID# 124089
mi
from 02139
Duncansville, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Altoona Ctr Clinical Res /ID# 124089
mi
from 02139
Duncansville, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Emkey Arthritis and Osteo Clin /ID# 135908
mi
from 02139
Wyomissing, PA
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Emkey Arthritis and Osteo Clin /ID# 135908
mi
from 02139
Wyomissing, PA
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Dr. Ramesh Gupta /ID# 128744
mi
from 02139
Memphis, TN
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Dr. Ramesh Gupta /ID# 128744
mi
from 02139
Memphis, TN
Click here to add this to my saved trials
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated:  12/31/1969
Austin Rheum. Research /ID# 124083
mi
from 02139
Austin, TX
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Rheumatoid Arthritis Subjects
A Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) With Upadacitinib (ABT-494)
Status: Enrolling
Updated: 12/31/1969
Austin Rheum. Research /ID# 124083
mi
from 02139
Austin, TX
Click here to add this to my saved trials